Nystatin and Splenomegaly - a phase IV clinical study of FDA data

Summary:

Splenomegaly is reported as a side effect among people who take Nystatin (nystatin), especially for people who are female, 60+ old, have been taking the drug for 6 - 12 months also take Lasix, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Splenomegaly when taking Nystatin. It is created by eHealthMe based on reports of 33,189 people who have side effects when taking Nystatin from the FDA, and is updated regularly.

What is Nystatin?

Nystatin has active ingredients of nystatin. It is often used in thrush. eHealthMe is studying from 33,567 Nystatin users. Check the latest studies of Nystatin.

What is Splenomegaly?

Splenomegaly (enlargement of spleen) is found to be associated with 1,118 drugs and 1,477 conditions by eHealthMe. Check the latest studies of Splenomegaly.

On Jul, 13, 2026

33,189 people reported to have side effects when taking Nystatin.
Among them, 65 people (0.2%) have Splenomegaly.

Among these 65 people:

How long have people been on Nystatin when they have Splenomegaly? *

What is the gender of people who have Splenomegaly when taking Nystatin? *

female: 63.33 %
male: 36.67 %

What is the age of people who have Splenomegaly when taking Nystatin? *

What are other drugs people take besides Nystatin? *

What are other side effects people have besides Splenomegaly? *

Ascites (accumulation of fluid in the abdominal cavity): 17 people, 26.15%
Pleural Effusion (water on the lungs): 16 people, 24.62%
Diarrhea: 15 people, 23.08%
Pain: 15 people, 23.08%
Enlarged Heart: 14 people, 21.54%
Atelectasis (partial or complete collapse of the lung): 14 people, 21.54%
Dyspnea (difficult or laboured breathing): 14 people, 21.54%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 14 people, 21.54%
Joint Pain: 14 people, 21.54%
Oedema Peripheral (superficial swelling): 13 people, 20.00%

What are the existing conditions these people have? *

Pain: 9 people, 13.85%
Multiple Myeloma (cancer of the plasma cells): 9 people, 13.85%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 5 people, 7.69%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 4 people, 6.15%
Nausea (feeling of having an urge to vomit): 4 people, 6.15%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 4 people, 6.15%
Primary Myelofibrosis (primary disorder of the bone marrow): 3 people, 4.62%
Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 3 people, 4.62%
Stress And Anxiety: 3 people, 4.62%
Polycythaemia Vera (blood disorder in which the bone marrow makes too many red blood cells): 2 people, 3.08%

* Approximation only. Some reports may have incomplete information.

Do you take Nystatin and have Splenomegaly?

- Check whether Splenomegaly is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Nystatin:

Nystatin (33,567 reports)

Splenomegaly treatments and more:

Splenomegaly (17,257 reports)

Browse all side effects of Nystatin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Splenomegaly:

Splenomegaly (1,117 drugs)

Browse all the conditions that are associated with Splenomegaly:

Splenomegaly (1,477 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on nystatin (the active ingredients of Nystatin) and Nystatin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.